|
Market Closed -
Sao Paulo
15:37:42 2026-08-24 EDT
|
5-day change | 1st Jan Change | ||
| 328.02 BRL | -0.20% |
|
+5.32% | +18.38% |
| 08-20 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| 08-20 | Canaccord Genuity Initiates Incyte at Buy With $152 Price Target | MT |
Company Valuation: Incyte Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 16,213 | 17,869 | 14,072 | 13,306 | 19,391 | 25,970 | - | - |
| Change | - | 10.21% | -21.25% | -5.44% | 45.73% | 33.93% | - | - |
| Enterprise Value (EV) 1 | 13,865 | 14,630 | 10,416 | 11,148 | 16,293 | 21,740 | 19,979 | 18,000 |
| Change | - | 5.52% | -28.81% | 7.03% | 46.15% | 33.43% | -8.1% | -9.91% |
| P/E | 17.2x | 52.8x | 23.7x | 460x | 15.4x | 57.2x | 17.7x | 16.3x |
| PBR | 4.32x | 4.09x | 2.71x | 3.88x | 3.79x | 4.38x | 3.3x | 2.6x |
| PEG | - | -0.8x | 0.3x | -4.9x | 0x | -0.9x | 0x | 1.9x |
| Capitalization / Revenue | 5.43x | 5.26x | 3.81x | 3.14x | 3.77x | 4.37x | 4.15x | 3.96x |
| EV / Revenue | 4.64x | 4.31x | 2.82x | 2.63x | 3.17x | 3.66x | 3.19x | 2.74x |
| EV / EBITDA | 21.5x | 24.5x | 14.8x | 22.2x | 9.53x | 28.3x | 9.4x | 9.02x |
| EV / EBIT | 23.7x | 25.2x | 16.8x | 26.9x | 10.1x | 25.2x | 8.78x | 7.09x |
| EV / FCF | 24.4x | 16.4x | 22.4x | 44.8x | - | 32.2x | 12.2x | 10.3x |
| FCF Yield | 4.1% | 6.1% | 4.45% | 2.23% | - | 3.11% | 8.17% | 9.72% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 4.27 | 1.52 | 2.65 | 0.15 | 6.41 | 2.241 | 7.239 | 7.859 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,986 | 3,395 | 3,696 | 4,241 | 5,141 | 5,942 | 6,265 | 6,566 |
| EBITDA 1 | 643.6 | 597.7 | 703.2 | 503.1 | 1,709 | 766.9 | 2,126 | 1,996 |
| EBIT 1 | 585.8 | 579.4 | 620.5 | 413.9 | 1,616 | 863.9 | 2,276 | 2,540 |
| Net income 1 | 948.6 | 340.7 | 597.6 | 32.62 | 1,287 | 465.8 | 1,496 | 1,696 |
| Net Debt 1 | -2,348 | -3,239 | -3,656 | -2,158 | -3,098 | -4,230 | -5,991 | -7,970 |
| Reference price 2 | 73.40 | 80.32 | 62.79 | 69.07 | 98.77 | 128.12 | 128.12 | 128.12 |
| Nbr of stocks (in thousands) | 220,891 | 222,475 | 224,109 | 192,650 | 196,323 | 202,698 | - | - |
| Announcement Date | 2/8/22 | 2/7/23 | 2/13/24 | 2/10/25 | 2/10/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 19.3x | 4.51x | 10.63x | 0.47% | 83.24B | |
| -18.57x | 28.37x | -18.46x | -.--% | 63.41B | |
| 20.45x | 4.36x | 13.46x | 2.43% | 59.49B | |
| 38.56x | 13.17x | 25.26x | -.--% | 52.94B | |
| 22.44x | 4.95x | 14.13x | 0.65% | 49.86B | |
| 39.23x | 3.6x | 13.71x | -.--% | 32.62B | |
| 57.89x | 3.71x | 28.77x | -.--% | 26.29B | |
| 72.74x | 7.16x | 48.17x | -.--% | 22.23B | |
| 24.61x | 5.28x | 13.74x | -.--% | 17.22B | |
| Average | 30.74x | 8.35x | 16.60x | 0.39% | 45.26B | |
| Weighted average by Cap. | 23.69x | 9.44x | 12.44x | 0.53% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- INCY Stock
- I1NC34 Stock
- Valuation Incyte Corporation
Select your edition
All financial news and data tailored to specific country editions
